Related Experiment Videos
Potential Vaccines for Treating Crohn's Disease
Mohammad Rostami-Nejad1, Mohammad Hossein Yazdi2,3, Shekoufeh Nikfar3,4
1Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Iranian Biomedical Journal
|August 27, 2019
Summary
New vaccines for Crohn
Area of Science:
- Gastroenterology
- Immunology
- Vaccinology
Background:
- Crohn's disease (CD) is a chronic gastrointestinal inflammatory disorder.
- Impaired mucosal barrier and bacteria like Mycobacterium avium are implicated in CD pathogenesis.
- Current treatments exist, but novel therapeutic strategies are needed.
Purpose of the Study:
- To review therapeutic opportunities for Crohn's disease over the past decade.
- To specifically evaluate the potential of vaccines as a novel treatment modality for CD.
- To discuss the expected advancements in CD vaccine development.
Main Methods:
- Comprehensive literature review of therapeutic approaches for Crohn's disease.
- Focus on vaccine development and immunotherapy strategies.
- Analysis of the role of Mycobacterium avium and mucosal barrier function.
Main Results:
- A new generation of vaccines for Crohn's disease is anticipated.
- Tolerogenic ex vivo-derived dendritic cell (DC)-based vaccines show promise.
- Therapeutic outcomes with DC-based vaccines may vary due to disease heterogeneity.
Conclusions:
- Vaccine development represents a novel frontier in Crohn's disease treatment.
- DC-based vaccines offer a promising avenue for immunotherapy.
- Personalized approaches may be necessary for effective DC-based vaccine therapy in CD.